The MACK chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the MACK chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.
The MACK stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.
View MACK Detailed Price Forecast - CNN Money | View MACK Detailed Summary - Google Finance | ||
View MACK Detailed Summary - Yahoo! Finance | View MACK Stock Research & Analysis - Zacks.com |
View MACK Trends & Analysis - Trade-Ideas | View MACK Major Holders - Barrons | ||
View MACK Call Transcripts - NASDAQ | View MACK Breaking News & Analysis - Seeking Alpha | ||
View MACK Annual Report - CompanySpotlight.com | View MACK OTC Short Report - OTCShortReport.com | ||
View MACK Fundamentals - TradeKing | View MACK SEC Filings - Bar Chart | ||
View Historical Prices for MACK - The WSJ | View Performance/Total Return for MACK - Morningstar | ||
View the Analyst Estimates for MACK - MarketWatch | View the Earnings History for MACK - CNBC | ||
View the MACK Earnings - StockMarketWatch | View MACK Buy or Sell Recommendations - MacroAxis | ||
View the MACK Bullish Patterns - American Bulls | View MACK Short Pain Metrics - ShortPainBot.com |
View MACK Stock Mentions - StockTwits | View MACK Stock Mentions - PennyStockTweets | ||
View MACK Stock Mentions - Twitter | View MACK Investment Forum News - Investor Hub | ||
View MACK Stock Mentions - Yahoo! Message Board | View MACK Stock Mentions - Seeking Alpha |
View Insider Transactions for MACK - SECform4.com | View Insider Transactions for MACK - Insider Cow | ||
View MACK Major Holdings Summary - CNBC | View Insider Disclosure for MACK - OTC Markets | ||
View Insider Transactions for MACK - Yahoo! Finance | View Institutional Holdings for MACK - NASDAQ |
View MACK Stock Insight & Charts - FinViz.com | View MACK Investment Charts - StockCharts.com | ||
View MACK Stock Overview & Charts - BarChart | View MACK User Generated Charts - Trading View |
Merrimack Receives $225 Million Milestone Payment from Ipsen
Posted on Wednesday March 27, 2024
CAMBRIDGE, Mass., March 27, 2024--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") today announced that it has received a $225 million payment which was due from Ipsen, S.A. as a result of its receipt of approval from the U.S. Food and Drug Administration, or FDA, to market ONIVYDE as a first-line treatment of metastatic adenocarcinoma on the pancreas.
Merrimack Reports Full Year 2023 Financial Results
Posted on Thursday March 07, 2024
CAMBRIDGE, Mass., March 07, 2024--Merrimack Reports Full Year 2023 Financial Results
Merrimack Pharmaceuticals, Inc. (NASDAQ:MACK) is definitely on the radar of hedge funds investors who own 35% of the company
Posted on Monday March 04, 2024
Key Insights Significantly high institutional ownership implies Merrimack Pharmaceuticals' stock price is sensitive to...
Merrimack Reports Ipsen Announcement of Approval By The US FDA of Onivyde® (Irinotecan Liposome Injection) Plus 5 Fluorouracil/Leucovorin and Oxaliplatin (NALIRIFOX) as a First-Line Treatment for Metastatic Pancreatic Ductal Adenocarcinoma (mPDAC)
Posted on Tuesday February 13, 2024
CAMBRIDGE, Mass., February 13, 2024--Merrimack Pharmaceuticals, Inc. (Nasdaq: MACK) ("Merrimack" or the "Company") reported that Ipsen, SA ("Ipsen") issued a press release today announcing the U.S. Food and Drug Administration has approved the supplemental new drug application for Onivyde® (irinotecan liposome injection) plus 5 fluorouracil/leucovorin and oxaliplatin (NALIRIFOX) as a first-line treatment for people living with metastatic pancreatic ductal adenocarcinoma (mPDAC).